AIMCA
AMRX icon

Alberta Investment Management Corp (AIMCo)’s Amneal Pharmaceuticals AMRX Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-131,267
Closed -$407K – 1050
2023
Q2 		$407K Hold
131,267
– – ﹤0.01% 989
2023
Q1 		$182K Hold
131,267
– – ﹤0.01% 1182
2022
Q4 		$261K Buy
+131,267
New +$294K ﹤0.01% 986
2020
Q4 		– Sell
-73,700
Closed -$286K – 854
2020
Q3 		$286K Hold
73,700
– – ﹤0.01% 889
2020
Q2 		$351K Buy
+73,700
New +$303K ﹤0.01% 907

Other funds holding AMRX

FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s AMRX Position: Q3 2023 in Review

Alberta Investment Management Corp (AIMCo) sold out of Amneal Pharmaceuticals (AMRX) in Q3 2023, closing a stake of 131,267 shares — an estimated $407K sold.

Alberta Investment Management Corp (AIMCo) first reported a position in AMRX in Q2 2020 and held it in 5 quarters. The position peaked at $407K in Q2 2023. 144 funds tracked by Wall St. Rank hold AMRX as of Q3 2023.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Amneal Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 131,267 Amneal Pharmaceuticals shares in Q3 2023, an estimated $407K.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Amneal Pharmaceuticals in Q2 2020 and held it in 5 quarters.
  • Alberta Investment Management Corp (AIMCo)'s Amneal Pharmaceuticals position peaked at $407K in Q2 2023.
  • 144 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2023.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q3 2023, filed 14 Nov 2023.